Article Console
Article-based scientific overview
The interface follows the article's central argument: TBI and Alzheimer's disease share
amyloid-beta and tau-related features, yet CTE shows distinct regional and vascular
patterns that complicate diagnosis and require targeted research.
01
Pathology overlap
Shared molecular features
The article emphasizes overlap between TBI and Alzheimer's-like pathology, especially
amyloid-beta deposition and hyperphosphorylated tau aggregates. These shared features
help explain why repetitive or severe injury may accelerate neurodegenerative processes.
02
Diagnostic friction
Why differential diagnosis is difficult
Clinical presentations overlap: memory impairment, executive dysfunction, mood symptoms
and behavioural changes may appear in both AD and CTE. Conventional imaging and broad
biomarkers often lack the specificity needed to separate TBI-related degeneration from
classical Alzheimer's disease.
03
Clinical implications
Prevention, early intervention and biomarkers
The article argues for stricter prevention in high-risk environments, earlier
intervention, longitudinal monitoring and advances in tau-specific imaging, blood-based
biomarkers and multimodal diagnostic models.
Feature
Alzheimer's Disease
Chronic Traumatic Encephalopathy
Primary driverAge-related and genetic risk factors, including APOE epsilon4.Repetitive head injuries or concussions.
Pathological hallmarksAmyloid-beta plaques and neurofibrillary tangles.Perivascular tau tangles and sulcal depth tauopathy.
Tau distributionEntorhinal cortex and hippocampus with outward progression.Laminae II/III of frontal and temporal cortices.
Clinical profileMemory loss, confusion and cognitive decline.Behavioural change, irritability and impulsivity.